J5J-OX-JZZA A Phase 1a/1b Trial of LY3962673 in Participants with KRAS G12D-Mutant Solid Tumors

Clinical Trial Grant

Duke Scholars

Principal Investigator John Strickler Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Lilly USA, LLC

Start Date

February 10, 2025

End Date

February 2, 2030

Administered By

Duke Cancer Institute

Awarded By

Lilly USA, LLC

Start Date

February 10, 2025

End Date

February 2, 2030